Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App may help diabetes patients stick with ozempic

NCT ID NCT06478550

First seen Jan 10, 2026 · Last updated May 18, 2026 · Updated 19 times

Summary

This study tested whether a smartphone app helps people with type 2 diabetes continue taking their Ozempic injections as prescribed. 304 participants either used the app or received standard care. The study tracked how long they stayed on the medication and if they reached their target dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • "Laiko" General Hospital of Athens

    Goudi/Athens, 11527, Greece

  • General Hospital Of Thessaloniki Papageorgiou

    Thessaloniki, Nea Efkarpia, 56429, Greece

  • General Hospital of Thessaloniki 'G. Gennimatas

    Thessaloniki, 54635, Greece

  • Geniko Nosokomeio Peiraia Tzaneio

    Piraeus, 18536, Greece

  • Univ Gen Hospital Larisa

    Larissa, 41110, Greece

  • University Hospital of Athens ATTIKON

    Athens, Attica, 12462, Greece

Conditions

Explore the condition pages connected to this study.